COGT - Cogent Biosciences, Inc.

QQQ $ 598.50 $ -4.01 (-0.67 %)

DIA $ 463.08 $ 2.03 (0.44 %)

SPY $ 662.74 $ -0.81 (-0.12 %)

TLT $ 90.69 $ 0.29 (0.32 %)

GLD $ 382.95 $ 2.70 (0.71 %)

Previous Close

$ 15.43

Open

$ 16.01

Bid

$ 14.70 x 200

Ask

$ 17.44 x 25

Day's Range

$ 15.35 - $ 16.22

52 Week Range

$ 3.72 - $ 16.99

Volume

1,440,132

Average Volume

Market Cap

2.16B

Beta (5Y Monthly)

$ 0.62

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-05-2025	06-30-2025	10-Q
2	05-06-2025	03-31-2025	10-Q
3	02-25-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-06-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	02-26-2024	12-31-2023	10-K
8	11-07-2023	09-30-2023	10-Q
9	08-08-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	03-14-2023	12-31-2022	10-K
12	11-14-2022	09-30-2022	10-Q
13	08-09-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	03-15-2022	12-31-2021	10-K
16	11-10-2021	09-30-2021	10-Q
17	08-16-2021	06-30-2021	10-Q
18	05-12-2021	03-31-2021	10-Q
19	03-16-2021	12-31-2020	10-K
20	11-09-2020	09-30-2020	10-Q
21	08-11-2020	06-30-2020	10-Q
22	05-11-2020	03-31-2020	10-Q
23	03-26-2020	12-31-2019	10-K
24	11-12-2019	09-30-2019	10-Q
25	08-12-2019	06-30-2019	10-Q
26	05-13-2019	03-31-2019	10-Q
27	03-28-2019	12-31-2018	10-K
28	11-13-2018	09-30-2018	10-Q
29	08-13-2018	06-30-2018	10-Q
30	05-14-2018	03-31-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Raymond James Initiates Coverage On Cogent...
09/03/2025 16:46:55

Raymond James analyst Chris Raymond initiates coverage on Cogent Biosciences (NASDAQ:COGT) with a Strong Buy rating and anno...

macys-increases-fy2025-outlook-joins-rev-group-healthequity-alphabet-and-wellness-and-other-big-stocks-moving-higher-on-wednesday

Macy's Increases FY2025 Outlook, Joins REV...
09/03/2025 14:10:50

Guggenheim Maintains Buy on Cogent Bioscie...
08/25/2025 12:21:28

Guggenheim analyst Charles Zhou maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $17 t...

JP Morgan Maintains Overweight on Cogent B...
08/07/2025 19:10:38

JP Morgan analyst Anupam Rama maintains Cogent Biosciences (NASDAQ:COGT) with a Overweight and raises the price target from ...

HC Wainwright & Co. Maintains Buy on Cogen...
08/06/2025 12:08:24

HC Wainwright & Co. analyst Robert Burns maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and lowers the price targ...

Cogent Biosciences Q2 EPS $(0.53) Beats $(...
08/05/2025 21:45:16

Cogent Biosciences (NASDAQ:COGT) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(...

Cogent Biosciences Cash Position As Of Jun...
08/05/2025 12:21:55

3-stocks-with-sky-high-overbought-signals-quantumscape-opendoor-cogent-flash-rsi-red-flags

3 Stocks With Sky-High Overbought Signals:...
07/21/2025 11:57:42

According to the technical analysis of over 4,400 firms with a market cap exceeding $100 million, three firms are in the overbo...

Citigroup Maintains Buy on Cogent Bioscien...
07/18/2025 16:35:39

Citigroup analyst David Lebowitz maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $15 ...

JP Morgan Maintains Overweight on Cogent B...
07/10/2025 18:45:57

JP Morgan analyst Anupam Rama maintains Cogent Biosciences (NASDAQ:COGT) with a Overweight and raises the price target from ...

Reported Earlier, Cogent Biosciences Price...
07/09/2025 06:14:58

Cogent Biosciences Announces Proposed $150...
07/08/2025 20:27:57

Cogent Biosciences, Inc. (NASDAQ: COGT), a biotechnology company focused on developing precision therapies for genetically defi...

cogents-chronic-immune-disorder-drug-has-strong-potential-to-become-a-blockbuster-analyst

Cogent's Chronic Immune Disorder Drug Has ...
07/08/2025 18:26:44

Cogent's bezuclastinib showed strong efficacy in a non-advanced SM trial, with a planned FDA submission expected by the end...

HC Wainwright & Co. Maintains Buy on Cogen...
07/08/2025 14:54:09

HC Wainwright & Co. analyst Robert Burns maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price targ...

Guggenheim Reiterates Buy on Cogent Biosci...
07/08/2025 13:56:21

Guggenheim analyst Michael Schmidt reiterates Cogent Biosciences (NASDAQ:COGT) with a Buy and maintains $17 price target.

Baird Maintains Neutral on Cogent Bioscien...
07/08/2025 13:12:41

Baird analyst Joel Beatty maintains Cogent Biosciences (NASDAQ:COGT) with a Neutral and raises the price target from $7 to $9.

us-stocks-likely-to-open-mixed-as-trump-issues-tariff-letters-experts-peg-ai-investments-as-durable-drivers-of-returns

US Stocks Likely To Open Mixed As Trump Is...
07/08/2025 10:24:03

U.S. stock futures were fluctuating on Tuesday after trimming gains on Monday. Futures of major benchmark indices were trading ...

trump-tariffs-sink-dow-over-400-points-investor-sentiment-declines-but-fear--greed-index-remains-in-extreme-greed-zone

Trump Tariffs Sink Dow Over 400 Points: In...
07/08/2025 06:37:32

Jefferies Maintains Buy on Cogent Bioscien...
07/07/2025 17:44:34

Jefferies analyst Kelly Shi maintains Cogent Biosciences (NASDAQ:COGT) with a Buy and raises the price target from $23 to $28.

Leerink Partners Maintains Outperform on C...
07/07/2025 17:10:07

Leerink Partners analyst Andrew Berens maintains Cogent Biosciences (NASDAQ:COGT) with a Outperform and raises the price tar...